His primary areas of investigation include Internal medicine, Gout, Cell biology, Inflammation and Endocrinology. He undertakes multidisciplinary investigations into Internal medicine and Generalized arterial calcification in his work. His Gout research includes elements of Arthritis, Intensive care medicine, Disease, Colchicine and Rheumatology.
The various areas that Robert Terkeltaub examines in his Cell biology study include Peroxynitrite, Chondrocyte, Biochemistry and Autophagy. His work carried out in the field of Inflammation brings together such families of science as Receptor, Innate immune system and Molecular biology. His research investigates the connection between Endocrinology and topics such as Calcification that intersect with problems in Extracellular and Cellular differentiation.
His primary areas of study are Internal medicine, Gout, Cell biology, Endocrinology and Chondrocyte. The various areas that he examines in his Internal medicine study include Gastroenterology, Osteoarthritis and Surgery. The concepts of his Gout study are interwoven with issues in Uric acid, Hyperuricemia, Inflammation, Allopurinol and Adverse effect.
His Inflammation research is multidisciplinary, relying on both Innate immune system and Phagocytosis. His work investigates the relationship between Cell biology and topics such as Biochemistry that intersect with problems in Calcium. His study explores the link between Chondrocyte and topics such as Extracellular that cross with problems in Molecular biology.
Robert Terkeltaub mainly investigates Gout, Internal medicine, Hyperuricemia, Cell biology and Febuxostat. The Gout study combines topics in areas such as Uric acid, Tophus, Immunology, Family medicine and Lesinurad. His work in Immunology tackles topics such as Phenotype which are related to areas like Inflammation.
Robert Terkeltaub frequently studies issues relating to Endocrinology and Internal medicine. His study in Endocrinology is interdisciplinary in nature, drawing from both Cartilage and Type II collagen. His Cell biology research integrates issues from Chondrocyte and Aggrecan.
Robert Terkeltaub spends much of his time researching Gout, Internal medicine, AMPK, Cell biology and Hyperuricemia. His biological study spans a wide range of topics, including Tophus, Medical literature, Chronic gout, Physical therapy and Kidney. His Internal medicine study integrates concerns from other disciplines, such as Cross-sectional study and Surgery.
His work deals with themes such as Endocrinology and Mitochondrial biogenesis, which intersect with AMPK. His research ties Mitochondrial DNA and Cell biology together. His Hyperuricemia research includes elements of Probenecid, Disease, Toxicity and Family medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna;John D. FitzGerald;Puja P. Khanna;Sangmee Bae.
Arthritis Care and Research (2012)
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization
Lovisa Hessle;Kristen A. Johnson;H. Clarke Anderson;Sonoko Narisawa.
Proceedings of the National Academy of Sciences of the United States of America (2002)
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.
Dinesh Khanna;Puja P. Khanna;John D. FitzGerald;Manjit K. Singh.
Arthritis Care and Research (2012)
A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.
W A Boisvert;R Santiago;L K Curtiss;R A Terkeltaub.
Journal of Clinical Investigation (1998)
Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification
Frank Rutsch;Nico Ruf;Sucheta Vaingankar;Mohammad R Toliat.
Nature Genetics (2003)
Clinical practice. Gout.
Robert A Terkeltaub.
The New England Journal of Medicine (2003)
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.
Dympna Harmey;Lovisa Hessle;Sonoko Narisawa;Kristen A. Johnson.
American Journal of Pathology (2004)
High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study
Robert A. Terkeltaub;Daniel E. Furst;Katherine Bennett;Karin A. Kook.
Arthritis & Rheumatism (2010)
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
S Hörkkö;E Miller;E Dudl;P Reaven.
Journal of Clinical Investigation (1996)
Inorganic pyrophosphate generation and disposition in pathophysiology
Robert A. Terkeltaub.
American Journal of Physiology-cell Physiology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: